Teva (TEVA) CEO Issues FY12 EPS, Sales Outlook
Tweet
Share
E-mailGet Alerts TEVA Hot Sheet
Join SI Premium – FREE
Speaking at a 2012 Business Outlook Conference Call, Teva's (Nasdaq: TEVA) CEO Shlomo Yanai is offering some guidance: sees FY12 EPS of $5.48-$5.68, which compares to the Street estimate of $5.67, on sales of about $22 billion, vs. the consensus of $21.97 billion.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Aurinia settles patent dispute with Teva over generic voclosporin
- Jack Henry (JKHY) Tops Q4 EPS by 13c
- Target (TGT) Tops Q2 EPS by $1.78, Beats on Revenue; Offers FY27 EPS Guidance
Create E-mail Alert Related Categories
GuidanceSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
